Table 2 PTCH1 variants of 15 NBCCS patients.

From: Clinical and genetic profiling of nevoid basal cell carcinoma syndrome in Korean patients by whole-exome sequencing

Case

Sex/age

DNA variants

Protein alteration

Location

Variant type

Classification

ACMG criteria

References

1

F/9

del 9q22.31–q22.33

 

Whole gene

Gross deletion

Pathogenic

 

Matsudate et al.17

2

M/37

Exon 13–15 deletion

 

Exon 13–15

Partial deletion

Pathogenic

 

Novel

3

M/56

c.290delA

p.Asn97Thrfs*20

Exon 2

Frameshift

Pathogenic

PVS1, PM2, PP5

Wilson et al.18

4

F/62

c.403C > T

p.Arg135*

Exon 3

Nonsense

Pathogenic

PVS1, PM2, PP5

Wicking et al.19

5

F/22

c.403C > T

p.Arg135*

Exon 3

Nonsense

Pathogenic

PVS1, PM2, PP5

Wicking et al.19

6

F/66

c.1347 + 1G > A

p.?

Intron 9

Splice site

Pathogenic

PVS1, PM2, PP5

Reinders et al.20

7

F/38

c.1347 + 1G > A

p.?

Intron 9

Splice site

Pathogenic

PVS1, PM2, PP5

Reinders et al.20

8

F/24

c.1847G > A

p.Ser616Asn

Exon 13

Missense

VUS

PM2, PP3

Novel

9

M/13

c.2251-3C > G

p.?

Intron 14

Splice site

VUS

PM2, PP3, BS3

Sun JS et al.21

10

F/35

c.2415dup

p.Val806Serfs*23

Exon 15

Frameshift

Likely pathogenic

PVS1, PM2

Novel

11

F/20

c.2422C > T

p.Gln808*

Exon 15

Nonsense

Likely pathogenic

PVS1, PM2

Waszak et al.22

12

F/34

c.2560 + 7C > T

p.?

Intron 15

Splice region

Likely benign

BS1, BP6

rs75576651

13

F/19

c.2678G > A

p.Arg893His

Exon 16

Missense

Likely benign

BS1, BP6

Tate et al.23

14

F/19

c.2802T > A

p.Tyr934*

Exon 17

Nonsense

Likely pathogenic

PVS1, PM2

Novel

15

M/60

c.3467T > G

p.Leu1156Arg

Exon 21

Missense

Likely pathogenic

PM2, PM6, PP3, PP5

Gianferante et al.24

  1. VUS variant of uncertain significance, PVS pathogenic very strong, PM pathogenic moderate, PP pathogenic supporting, BS benign strong, BP benign supporting.